ICG |
Indocyanine green (ICG) |
JQ1 |
Thienotriazolodiazepine |
BMS (BMS986205) |
Linrodostat |
ICD |
Immunogenic cell death |
PTT |
Photothermal therapy |
CpG |
cytosine-guanine dinucleotides |
PD-1/PD-L1 |
Programmed cell death-1/Programmed cell death ligand-1 |
IDO-1 |
Indoleamine 2,3-dioxygenase 1 |
MIRDs |
Polyphenols coating ICG loaded magnetic nanoparticles |
DPA-PEG |
Dopamine-Poly(ethylene glycol) |
R837 |
Near-infrared heptamethine cyanine dye |
NC |
Nanocomplex |
Ce6 |
Chlorin e6 (Photosensitizer) |
PyroR |
Pyropheophorbide-A and Resiquimod |
ROS |
Reactive oxygen species |
CTTPA-G |
(Cancer cell membranes (CC-Ms) and TTPA and Glutamine) |
Type I AIE photosensitizer (TTPA): AIE |
Aggregation Induced Emission |
TTPA |
Terephthalic acid |
Pep-PAPM |
(peptide PEP-associated protein micelles) |
PEP |
Phosphoenolpyruvate |
TNBC |
Triple-negative breast cancer |
231MARS |
231 membrane artesunate |
PLGA |
Poly(lactic-co-glycolic acid) |
SK |
Shikonin |
TGF-β |
Tumour Growth Factor-β |
5-ASA |
(5-aminosalicylic acid) |
DOX |
Doxorubicin |
IR783 |
Near-infrared heptamethine cyanine dye |
mTOR |
mammalian Target of Rapamycin |
CTL |
Cytotoxic T lymphocyte |
BMS/RA@CC Liposome |
(BMS-202/RA-V@CT26 cancer cells biomimetic) |
BMS202 |
PD-1/PD-L1 inhibitor 2 |
RA-V |
Deoxybouvardin (Chemotherapeutic drug) |
MGTe |
Fusing TM and BM on the surface of glutathione (GSH) decorated Te nanoparticles (GTe) |
TM |
Tumour cell membrane |
BM |
Bacterial cell membrane |
APC |
Antigen-presenting cells |
PGA |
Poly (glycolic acid) |
IFN |
Interferon |
mAb |
monoclonal antibody |
HSP 70/90 |
Heat shock protein 70/90 |
MHC-I/II |
Major Histocompatibility Complex-I/II |
TGF β |
Tumour growth factor |
EZH2 |
Enhancer of zeste homolog 2 |
LPS |
Lipopolysaccharide |
TLR |
Toll-like receptor |
MUC1 |
Mucin 1 |
Dex |
Dexamethasone |
ZNPs/I@CML |
ZSTK carrier-free nanoparticle/Indomethacin@cancer-derived membrane/liposome |
PI3K |
Phosphoinositide 3-kinase |
PLG |
Poly(DL-Lactide-co-Glycolide) |
ZSTK |
ZSTK474 (PI3K inhibitor) |
MCP 1 |
Monocyte chemoattractant protein-1 |
TNF 2 |
Tumour necrosis factor |
UPP |
Unripe plantain peel |
OVA |
Ovalbumin |
YP and Er NaY/GdF4 |
Yttrium phosphide and Erbium Sodium;Yttrium/Gadolinium fluoride |
UCNPs |
Up conversion nanoparticles |
iRGD peptide |
9-amino acid cyclic peptide (sequence: CRGDKGPDC) |
NSCLC |
Non-small cell lung cancer |
PCL |
Polycaprolactone |
CaCO3
|
Calcium carbonate |
EPC |
Egg yolk phosphatidylcholine |
Span85 |
Sorbitan trioleate |
GM-CSF |
Granulocyte-macrophage colony-stimulating factor |
ODN |
oligodeoxynucleotides |
CS/γ-PGA |
(Chitosan/Poly(gamma glutamic acid)) |
IgG |
Immunoglobulin G |
CTX |
cyclophosphamide |
PLEL |
poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide) |
HPAA |
Hydroxyphosphono-Acetic Acid |
PpASE |
PEG-poly (AGE-Suc) with etiphosphate |
ANLs |
Synthetic long peptides |
ANSs |
MHC-I epitope restricted peptides |
Mn-NP |
Manganese nanoparticle |
cGAS |
cyclic GMP-AMP Synthase |
STING |
Stimulation of interferon genes |
s.c. |
Subcutaneous |
i.v. |
Intravenous |
DGBA |
Guanidinobenzoic acid |
NLRP3 |
NLR (Nod-like receptor) family pyrin domain containing 3 |
iNOS |
Inducible nitric oxide synthase |